Hosey Megan M, Wegener Stephen T, Hinkle Caroline, Needham Dale M
Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
J Clin Med. 2021 Feb 20;10(4):872. doi: 10.3390/jcm10040872.
The number of people surviving critical illness is rising rapidly around the globe. Survivorship comes at a cost, with approximately half of patients with acute respiratory failure (ARF) experiencing clinically significant symptoms of anxiety, and 32-40% of survivors having substantial anxiety symptoms in the months or years after hospitalization.
This feasibility study reports on 11 consecutive ARF patients receiving up to six sessions of a psychological intervention for self-management of anxiety.
All 11 patients accepted and received the psychological intervention. Four patients did not fully complete all 6 sessions due to death ( = 1, 2 sessions completed), and early hospital discharge ( = 3, patients completed 2, 3 and 5 sessions). The median (IQR) score (range: 0-100; minimal clinically important difference: 13) for the Visual Analog Scale-Anxiety (VAS-A) pre-intervention was 70 (57, 75) points. During the intervention, all 11 patients had a decrease in VAS-A, with a median (IQR) decrease of 44 (19, 48) points.
This self-management intervention appears acceptable and feasible to implement among ARF patients during and after an ICU stay.
全球危重病幸存者的数量正在迅速增加。生存是有代价的，大约一半的急性呼吸衰竭（ARF）患者出现临床上显著的焦虑症状，32%-40%的幸存者在住院后的数月或数年中有明显的焦虑症状。
本可行性研究报告了11例连续的ARF患者接受了多达6次的焦虑自我管理心理干预。
所有11例患者均接受并接受了心理干预。4例患者由于死亡（1例，完成2次治疗）和提前出院（3例，患者分别完成2次、3次和5次治疗）未完全完成所有6次治疗。干预前视觉模拟量表-焦虑（VAS-A）的中位数（IQR）评分（范围：0-100；最小临床重要差异：13）为70（57，75）分。在干预期间，所有11例患者的VAS-A评分均下降，中位数（IQR）下降44（19，48）分。
这种自我管理干预在ICU住院期间及之后的ARF患者中似乎是可接受且可行的。
